40 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
27 Apr 23
Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022
4:26pm
and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
14 Dec 22
Entry into a Material Definitive Agreement
9:18am
subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon
DEFA14A
ALBT
Avalon GloboCare Corp
12 Dec 22
Additional proxy soliciting materials
10:41am
integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role
8-K
EX-99.1
l6ade2d8pvlm6
8 Nov 22
Entry into a Material Definitive Agreement
9:15am
8-K
EX-99.1
e78u2fvn v81b2ish
2 May 22
Regulation FD Disclosure
4:00pm
8-K
EX-99.1
lh52t
4 Jan 22
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
9:05am
8-K
EX-99.1
7xvaj 7z65nsk
22 Dec 21
Entry into a Material Definitive Agreement
11:17am
PRER14A
0q9fu694qnvw mqg
3 Sep 21
Preliminary revised proxy
4:06pm